Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00169416 | Evaluation Of Valaciclovir In Patients With Chickenpox | PHASE3 | COMPLETED | 43 | — | — | Mar 1, 2005 | Aug 1, 2005 | Apr 15, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| valaciclovir HCl granules | DRUG | - |
Inclusion criteria: * Subjects aged 1 year to less than 12 years with a clinical diagnosis of chickenpox within 48 hours of the onset of the rash. Exclusion criteria: * History of hypersensitivity reactions. * Impaired hepatic or renal function. * Gastrointestinal dysfunction. * Serious underlyin...